Treatment with a high daily dose bromocriptine was evaluated in 6 Cushing's disease patients
Abstract.
Treatment with a high daily dose bromocriptine was evaluated in 6 Cushing's disease patients (4 females and 2 males; aged 23 to 56 years). The highest doses administered were 40mg to patient 1, 55 sponse of plasma ACTH and cortisol to arginine in patient 2 ( Fig. 2-a) and to TRH in patient 3 (Fig  2-b) Fig. 2-a) . In patient 3, there was persistence of the paradoxical response of plasma ACTH and cortisol to TRH during the 7-year remission period after the therapeutic regimen with pituitary irradiation and reserpine. Such an abnormal response was still apparent when tested 6 and 8.7 months after the start of 5 to 35mg/day bromocriptine therapy (Fig. 2-b) 3. Plasma cortisol suppressibility with 1 or 8mg
oral Dex (Fig. 3 4. Plasma cortisol circadian rhythm (Fig. 4) In the pre-bromocriptine period, the normal plasma cortisol circadian rhythm was not apparent in all the patients but was apparent in patient 5, high daily dose bromocriptine, patient 1 (Fig. 3-a and [9]), patient 2 ( Fig. 3-b and [10] ), and patient 3 (Fig. 3-c) . 
